Why Did NextCure Stock 3X In One Session? - NextCure (NASDAQ:NXTC)

NextCure will merge with Avere in a $320 million exchange to advance oral IL-23 therapy AVR-001 and list the combined company as AVRX.

Raccontata dabenzinga.com